Growth Metrics

Kiniksa Pharmaceuticals International (KNSA) Change in Acquisitions & Divestments (2021 - 2025)

Kiniksa Pharmaceuticals International's Change in Acquisitions & Divestments history spans 5 years, with the latest figure at $40.8 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments fell 53.38% year-over-year to $40.8 million; the TTM value through Dec 2025 reached $199.5 million, down 16.86%, while the annual FY2025 figure was $199.5 million, 16.86% down from the prior year.
  • Change in Acquisitions & Divestments reached $40.8 million in Q4 2025 per KNSA's latest filing, down from $84.1 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $139.2 million in Q1 2021 to a low of $7.5 million in Q1 2022.
  • Average Change in Acquisitions & Divestments over 5 years is $52.5 million, with a median of $45.0 million recorded in 2023.
  • Peak YoY movement for Change in Acquisitions & Divestments: tumbled 94.61% in 2022, then soared 312.56% in 2024.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $10.0 million in 2021, then soared by 101.0% to $20.1 million in 2022, then surged by 128.75% to $46.0 million in 2023, then skyrocketed by 90.26% to $87.5 million in 2024, then crashed by 53.38% to $40.8 million in 2025.
  • Per Business Quant, the three most recent readings for KNSA's Change in Acquisitions & Divestments are $40.8 million (Q4 2025), $84.1 million (Q3 2025), and $30.6 million (Q2 2025).